Cargando…
Comment on Melatonin as a potential adjuvant treatment for COVID-19
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192085/ https://www.ncbi.nlm.nih.gov/pubmed/32360622 http://dx.doi.org/10.1016/j.lfs.2020.117739 |
_version_ | 1783527958265200640 |
---|---|
author | Herrera, Emilio A. González-Candia, Alejandro |
author_facet | Herrera, Emilio A. González-Candia, Alejandro |
author_sort | Herrera, Emilio A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7192085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71920852020-04-30 Comment on Melatonin as a potential adjuvant treatment for COVID-19 Herrera, Emilio A. González-Candia, Alejandro Life Sci Commentary Elsevier Inc. 2020-07-15 2020-04-30 /pmc/articles/PMC7192085/ /pubmed/32360622 http://dx.doi.org/10.1016/j.lfs.2020.117739 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Herrera, Emilio A. González-Candia, Alejandro Comment on Melatonin as a potential adjuvant treatment for COVID-19 |
title | Comment on Melatonin as a potential adjuvant treatment for COVID-19 |
title_full | Comment on Melatonin as a potential adjuvant treatment for COVID-19 |
title_fullStr | Comment on Melatonin as a potential adjuvant treatment for COVID-19 |
title_full_unstemmed | Comment on Melatonin as a potential adjuvant treatment for COVID-19 |
title_short | Comment on Melatonin as a potential adjuvant treatment for COVID-19 |
title_sort | comment on melatonin as a potential adjuvant treatment for covid-19 |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192085/ https://www.ncbi.nlm.nih.gov/pubmed/32360622 http://dx.doi.org/10.1016/j.lfs.2020.117739 |
work_keys_str_mv | AT herreraemilioa commentonmelatoninasapotentialadjuvanttreatmentforcovid19 AT gonzalezcandiaalejandro commentonmelatoninasapotentialadjuvanttreatmentforcovid19 |